Filings

7 documents · 15 matches

1. VIR Vir Biotechnology, Inc. 10-Q 2026-11-04

   Item 1A. Risk Factors.

   remedy any material weakness in our internal control over financial reporting could also restrict our future access to the capital markets.
   2 matches in this document Show context Copy citation

2. VIR Vir Biotechnology, Inc. 10-Q 2026-08-05

   Item 1A. Risk Factors.

   remedy any material weakness in our internal control over financial reporting could also restrict our future access to the capital markets.
   2 matches in this document Show context Copy citation

3. VIR Vir Biotechnology, Inc. 10-Q 2026-05-07

   Item 1A. Risk Factors.

   remedy any material weakness in our internal control over financial reporting could also restrict our future access to the capital markets.
   2 matches in this document Show context Copy citation

4. VIR Vir Biotechnology, Inc. 10-K 2026-02-23

   Item 1A. Risk Factors.

   remedy any material weakness in our internal control over financial reporting could also restrict our future access to the capital markets.
   3 matches in this document Show context Copy citation

5. VIR Vir Biotechnology, Inc. 10-Q 2025-11-05

   Item 1A. Risk Factors.

   remedy any material weakness in our internal control over financial reporting could also restrict our future access to the capital markets.
   2 matches in this document Show context Copy citation

6. VIR Vir Biotechnology, Inc. 10-Q 2025-08-06

   Item 1A. Risk Factors.

   remedy any material weakness in our internal control over financial reporting could also restrict our future access to the capital markets.
   2 matches in this document Show context Copy citation

7. VIR Vir Biotechnology, Inc. 10-Q 2025-05-08

   Item 1A. Risk Factors.

   remedy any material weakness in our internal control over financial reporting could also restrict our future access to the capital markets.
   2 matches in this document Show context Copy citation